Akèy › Limfom Difize Gwo Selil B › Wisconsin › La Crosse
Etid klinik pou Limfom Difize Gwo Selil B nan La Crosse, WI
3 etid pou Limfom Difize Gwo Selil B ap chèche patisipan nan sit nan ak bò kote La Crosse (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
Ap rekriteFaz 2
- Mayo Clinic Health System-Franciscan Healthcare, La Crosse
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Ap rekriteFaz 2
- Gundersen Lutheran Medical Center, La Crosse
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Ap rekriteFaz 2
- Gundersen Lutheran Medical Center, La Crosse
Etid Limfom Difize Gwo Selil B nan lòt vil
- New York City, NY21 etid
- Baldwin Park, CA19 etid
- Chicago, IL18 etid
- Houston, TX17 etid
- Los Angeles, CA17 etid
- Boston, MA16 etid
- Milwaukee, WI16 etid
- Nashville, TN15 etid
- Portland, OR15 etid
- Philadelphia, PA15 etid
- Durham, NC14 etid
- Dallas, TX13 etid
Lòt etid nan La Crosse
- Kansè Poumon ki pa ti selil10 etid
- Kansè poumon9 etid
- Leksemi mieloïd egi6 etid
- Kansè nan tete6 etid
- Myelom Miltip4 etid
- Karsinòm selil skuamèz tèt ak kou3 etid
- Kansè larinks3 etid
- Kansè bouch3 etid
- Melanom3 etid
- Kansè Endomèt3 etid
- Kansè ovè3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.